Lonza努力做大医药中间体业务

Lonza striving to develop pharmaceutical intermediates business

隆查 (Lonza)公司正把经营重点向独立合成和生物技术转移 ,努力进行结构调整 ,大力拓宽销售领域 ,争取做大医药中间体业务。介绍了其在发展生物技术、生产现状和销售渠道等方面的内容。

Lonza is changing its business to the independent synthesis and bio technology.It is striving to reform its own construction,expand its sales areas,and scale up pharmaceutical intermediate business.The development of biotechnology,current situation of production and sales channels of Lonza are introduced.